#Experimental condition mappings as of Feb 25, 2022 #WITH_INFO WITH_INFO term conditionClassId ZECO term conditionStatement CHEBI:46631 clonidine ZECO:0000111 chemical treatment chemical treatment:clonidine CHEBI:50845 doxycycline ZECO:0000111 chemical treatment chemical treatment:doxycycline XCO:0000005 running on treadmill ZECO:0000131 stress XCO:0000010 air oxygen content ZECO:0000131 stress XCO:0000013 diet ZECO:0000112 diet XCO:0000014 controlled content diet ZECO:0000112 diet XCO:0000015 controlled calorie content diet ZECO:0000112 diet XCO:0000017 nephrectomy ZECO:0000229 physical alteration XCO:0000018 bilateral nephrectomy ZECO:0000229 physical alteration physical alteration:bilateral nephrectomy XCO:0000022 controlled sodium content diet ZECO:0000112 diet diet:controlled sodium content diet XCO:0000025 controlled fat content diet ZECO:0000112 diet XCO:0000030 controlled protein content diet ZECO:0000112 diet XCO:0000032 controlled potassium content diet ZECO:0000239 chemical treatment by diet XCO:0000048 auditory stimulus ZECO:0000131 stress stress:auditory stimulus XCO:0000055 tactile electric shock exposure ZECO:0000131 stress XCO:0000056 naive control condition ZECO:0000101 control conditions XCO:0000069 standard diet ZECO:0000101 control conditions XCO:0000090 "7,12-dimethyltetraphene (DMBA)" ZECO:0000111 chemical treatment "chemical treatment:7,12-dimethyltetraphene (DMBA)" XCO:0000092 17 beta-estradiol ZECO:0000111 chemical treatment chemical treatment:17 beta-estradiol XCO:0000094 ovariectomy ZECO:0000229 physical alteration physical alteration:ovariectomy XCO:0000100 sham surgical control condition ZECO:0000101 control conditions XCO:0000102 fasting ZECO:0000113 food availability XCO:0000103 glucose solution ZECO:0000111 chemical treatment XCO:0000112 unilateral nephrectomy ZECO:0000229 physical alteration physical alteration:unilateral nephrectomy XCO:0000113 right nephrectomy ZECO:0000229 physical alteration physical alteration:right nephrectomy XCO:0000114 left nephrectomy ZECO:0000229 physical alteration XCO:0000121 NG-nitroarginine methyl ester ZECO:0000111 chemical treatment XCO:0000135 receptor agonist ZECO:0000111 chemical treatment XCO:0000143 acetylcholine ZECO:0000111 chemical treatment XCO:0000145 phenylephrine ZECO:0000111 chemical treatment XCO:0000154 ion/salt solution ZECO:0000111 chemical treatment XCO:0000155 sodium chloride solution ZECO:0000111 chemical treatment XCO:0000157 physical restraint ZECO:0000131 stress stress:physical restraint XCO:0000158 physical restraint in mechanical restrainer ZECO:0000131 stress XCO:0000159 physical restraint in tube type rodent restrainer ZECO:0000131 stress XCO:0000160 receptor antagonist ZECO:0000111 chemical treatment XCO:0000163 controlled content drinking water ZECO:0000112 diet XCO:0000164 controlled sodium content drinking water ZECO:0000112 diet diet:controlled sodium content drinking water XCO:0000165 surgical manipulation ZECO:0000229 physical alteration XCO:0000168 controlled in situ renal perfusion pressure ZECO:0000229 physical alteration XCO:0000177 thrombin ZECO:0000111 chemical treatment XCO:0000178 thapsigargin ZECO:0000111 chemical treatment XCO:0000181 controlled visible light condition ZECO:0000146 lighting conditions XCO:0000184 calcium ion ZECO:0000111 chemical treatment XCO:0000185 calcium ion solution ZECO:0000111 chemical treatment XCO:0000191 angiotensin II ZECO:0000111 chemical treatment XCO:0000192 deoxycorticosterone acetate ZECO:0000111 chemical treatment XCO:0000193 peptide/protein ZECO:0000111 chemical treatment XCO:0000195 myelin oligodendrocyte glycoprotein ZECO:0000105 biological treatment biological treatment:myelin oligodendrocyte glycoprotein XCO:0000201 orchiectomy ZECO:0000229 physical alteration XCO:0000203 bilateral orchiectomy ZECO:0000229 physical alteration XCO:0000206 N-nitrosodiethylamine ZECO:0000111 chemical treatment chemical treatment:N-nitrosodiethylamine XCO:0000207 3-methyl-4'-dimethylaminoazobenzene ZECO:0000111 chemical treatment XCO:0000210 partial hepatectomy ZECO:0000229 physical alteration XCO:0000211 controlled sucrose content diet ZECO:0000239 chemical treatment by diet XCO:0000212 controlled copper content diet ZECO:0000112 diet diet:controlled copper content diet XCO:0000228 peptide hormone ZECO:0000111 chemical treatment XCO:0000231 anti-RT6.1 antibody ZECO:0000111 chemical treatment XCO:0000235 Poly I:C ZECO:0000111 chemical treatment chemical treatment:Poly I:C XCO:0000237 viral pathogen ZECO:0000105 biological treatment XCO:0000238 Kilham rat virus ZECO:0000105 biological treatment biological treatment:Kilham rat virus XCO:0000240 toxin ZECO:0000111 chemical treatment XCO:0000241 streptozotocin ZECO:0000111 chemical treatment chemical treatment:streptozotocin XCO:0000244 controlled fructose content diet ZECO:0000112 diet diet:controlled fructose content diet XCO:0000245 insulin ZECO:0000111 chemical treatment XCO:0000246 controlled cholesterol content diet ZECO:0000112 diet XCO:0000252 tolbutamide ZECO:0000111 chemical treatment XCO:0000255 anti-glomerular basement membrane antibody ZECO:0000105 biological treatment biological treatment:anti-glomerular basement membrane antibody XCO:0000256 isoproterenol ZECO:0000111 chemical treatment XCO:0000262 collagen ZECO:0000111 chemical treatment XCO:0000263 pristane ZECO:0000111 chemical treatment chemical treatment:pristane XCO:0000264 Freund's adjuvant ZECO:0000111 chemical treatment XCO:0000265 Freund's incomplete adjuvant ZECO:0000111 chemical treatment chemical treatment:Freund's incomplete adjuvant XCO:0000266 Freund's complete adjuvant ZECO:0000111 chemical treatment chemical treatment:Freund's complete adjuvant XCO:0000268 balloon angioplasty ZECO:0000229 physical alteration XCO:0000270 captopril ZECO:0000111 chemical treatment chemical treatment:captopril XCO:0000273 carrageenan ZECO:0000111 chemical treatment XCO:0000275 glucose ZECO:0000111 chemical treatment chemical treatment:glucose XCO:0000280 squalene ZECO:0000111 chemical treatment chemical treatment:squalene XCO:0000281 type II collagen ZECO:0000105 biological treatment biological treatment:type II collagen XCO:0000282 anti-Thy1 antibody ZECO:0000105 biological treatment biological treatment:anti-Thy1 antibody XCO:0000283 visible light stimulus ZECO:0000146 lighting conditions XCO:0000285 controlled NG-nitroarginine methyl ester content drinking water ZECO:0000239 chemical treatment by diet XCO:0000288 R16 peptide of interphotoreceptor retinoid-binding protein ZECO:0000105 biological treatment biological treatment:R16 peptide of interphotoreceptor retinoid-binding protein XCO:0000291 peripheral myelin protein 2 peptide 58-81 ZECO:0000105 biological treatment biological treatment:peripheral myelin protein 2 peptide 58-81 XCO:0000292 peripheral nerve myelin ZECO:0000105 biological treatment biological treatment:peripheral nerve myelin XCO:0000295 diethylstilbestrol ZECO:0000111 chemical treatment chemical treatment:diethylstilbestrol XCO:0000296 running on inclined treadmill ZECO:0000131 stress XCO:0000297 fluid deprivation ZECO:0000112 diet XCO:0000298 controlled saccharin content drinking water ZECO:0000239 chemical treatment by diet XCO:0000304 bilateral adrenalectomy ZECO:0000229 physical alteration XCO:0000306 cold exposure ZECO:0000160 temperature exposure XCO:0000307 cold ambient air exposure ZECO:0000160 temperature exposure XCO:0000308 heat exposure ZECO:0000160 temperature exposure XCO:0000310 guanethidine ZECO:0000111 chemical treatment XCO:0000312 potassium chloride solution ZECO:0000111 chemical treatment XCO:0000317 buffered calcium ion solution ZECO:0000111 chemical treatment XCO:0000325 ethanol ZECO:0000111 chemical treatment chemical treatment:ethanol XCO:0000329 controlled deoxycorticosterone content saline drink ZECO:0000239 chemical treatment by diet XCO:0000337 air-jet exposure ZECO:0000131 stress stress:air-jet exposure XCO:0000341 chemical with specified function ZECO:0000111 chemical treatment XCO:0000345 N-ethyl-N-nitrosourea ZECO:0000111 chemical treatment XCO:0000348 middle cerebral artery occlusion ZECO:0000229 physical alteration physical alteration:middle cerebral artery occlusion XCO:0000351 4-nitroquinoline N-oxide ZECO:0000111 chemical treatment chemical treatment:4-nitroquinoline N-oxide XCO:0000356 spinal cord homogenate ZECO:0000105 biological treatment biological treatment:spinal cord homogenate XCO:0000367 sham surgical device implantation ZECO:0000101 control conditions XCO:0000369 aurothiopropanol sulfonate ZECO:0000111 chemical treatment chemical treatment:aurothiopropanol sulfonate XCO:0000372 dexamethasone ZECO:0000111 chemical treatment XCO:0000373 surgical denervation ZECO:0000229 physical alteration XCO:0000382 controlled captopril content drinking water ZECO:0000112 diet diet:controlled captopril content drinking water XCO:0000392 nucleoside/nucleotide ZECO:0000111 chemical treatment XCO:0000393 "1,2-dimethylhydrazine" ZECO:0000111 chemical treatment "chemical treatment:1,2-dimethylhydrazine" XCO:0000397 bisphenol A ZECO:0000111 chemical treatment XCO:0000432 sucrose ZECO:0000111 chemical treatment XCO:0000437 controlled N-propyl-N-nitrosourea content drinking water ZECO:0000112 diet diet:controlled N-propyl-N-nitrosourea content drinking water XCO:0000438 candesartan ZECO:0000111 chemical treatment XCO:0000442 controlled 2-acetamidofluorene content diet ZECO:0000239 chemical treatment by diet XCO:0000444 controlled dexamethasone content drinking water ZECO:0000239 chemical treatment by diet XCO:0000451 Herpes simplex virus type 1 ZECO:0000105 biological treatment biological treatment:Herpes simplex virus type 1 XCO:0000452 controlled casein content diet ZECO:0000112 diet XCO:0000464 controlled ex vivo organ condition ZECO:0000229 physical alteration XCO:0000466 controlled ex vivo artery perfusion pressure ZECO:0000229 physical alteration XCO:0000468 vitamin A ZECO:0000111 chemical treatment XCO:0000469 isotretinoin ZECO:0000111 chemical treatment chemical treatment:isotretinoin XCO:0000483 antibacterial agent ZECO:0000111 chemical treatment XCO:0000498 oxidopamine ZECO:0000111 chemical treatment XCO:0000520 neuromodulation ZECO:0000223 electric field XCO:0000521 direct electrical nerve stimulation ZECO:0000223 electric field XCO:0000522 common peroneal nerve direct electrical stimulation ZECO:0000223 electric field XCO:0000529 gene transfer using adenovirus vector ZECO:0000105 biological treatment XCO:0000535 lisinopril ZECO:0000111 chemical treatment XCO:0000537 olmesartan medoxomil ZECO:0000111 chemical treatment chemical treatment:olmesartan medoxomil XCO:0000539 doxorubicin ZECO:0000111 chemical treatment XCO:0000542 enalapril ZECO:0000111 chemical treatment XCO:0000545 vitamin D3 ZECO:0000111 chemical treatment XCO:0000547 paricalcitol ZECO:0000111 chemical treatment XCO:0000548 ramipril ZECO:0000111 chemical treatment XCO:0000551 hydralazine ZECO:0000111 chemical treatment XCO:0000555 controlled lisinopril content drinking water ZECO:0000239 chemical treatment by diet XCO:0000561 antidepressant ZECO:0000111 chemical treatment XCO:0000587 intracerebroventricular cannula implantation ZECO:0000229 physical alteration XCO:0000588 Perindopril ZECO:0000111 chemical treatment chemical treatment:Perindopril XCO:0000591 quinapril ZECO:0000111 chemical treatment XCO:0000592 cilazapril ZECO:0000111 chemical treatment XCO:0000599 aldosterone ZECO:0000111 chemical treatment XCO:0000600 "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)" ZECO:0000111 chemical treatment XCO:0000602 rosiglitazone ZECO:0000111 chemical treatment chemical treatment:rosiglitazone XCO:0000610 morphine ZECO:0000111 chemical treatment XCO:0000612 Endothelin-1 ZECO:0000111 chemical treatment XCO:0000613 Adenosine triphosphate ZECO:0000111 chemical treatment XCO:0000630 cholinergic antagonist ZECO:0000111 chemical treatment XCO:0000637 cyclosporine A ZECO:0000111 chemical treatment XCO:0000638 Capsazepine ZECO:0000111 chemical treatment XCO:0000641 Myocardial reperfusion ZECO:0000229 physical alteration XCO:0000642 monocrotaline ZECO:0000111 chemical treatment XCO:0000644 anti-T cell receptor antibody ZECO:0000111 chemical treatment XCO:0000645 propofol ZECO:0000111 chemical treatment chemical treatment:propofol XCO:0000646 Azoxymethane ZECO:0000111 chemical treatment chemical treatment:Azoxymethane XCO:0000649 trans-4-hydroxy-L-proline ZECO:0000111 chemical treatment chemical treatment:trans-4-hydroxy-L-proline XCO:0000655 prion ZECO:0000105 biological treatment biological treatment:prion XCO:0000658 nisoldipine ZECO:0000111 chemical treatment chemical treatment:nisoldipine XCO:0000662 "two-kidney, one-clip occlusion" ZECO:0000229 physical alteration XCO:0000667 clenbuterol ZECO:0000111 chemical treatment XCO:0000668 arterial catheter implantation and controlled hemorrhage ZECO:0000229 physical alteration XCO:0000669 diazoxide ZECO:0000111 chemical treatment XCO:0000670 Pair-fed diet ZECO:0000112 diet XCO:0000675 gene transfer using retrovirus vector ZECO:0000105 biological treatment XCO:0000677 controlled enalapril content drinking water ZECO:0000239 chemical treatment by diet XCO:0000679 fenofibrate ZECO:0000111 chemical treatment XCO:0000681 Medica 16 ZECO:0000111 chemical treatment XCO:0000682 Benfluorex ZECO:0000111 chemical treatment XCO:0000683 cholestyramine ZECO:0000111 chemical treatment XCO:0000688 myelin basic protein ZECO:0000105 biological treatment biological treatment:myelin basic protein XCO:0000691 controlled vitamin C content diet ZECO:0000239 chemical treatment by diet XCO:0000703 "2,4,5 trimethylthiazoline" ZECO:0000111 chemical treatment XCO:0000704 carotid artery occlusion ZECO:0000229 physical alteration physical alteration:carotid artery occlusion XCO:0000709 cancer cells ZECO:0000105 biological treatment XCO:0000727 splenectomy ZECO:0000229 physical alteration XCO:0000731 controlled enrasentan content diet ZECO:0000112 diet diet:controlled enrasentan content diet XCO:0000734 chemerin-9 ZECO:0000111 chemical treatment XCO:0000735 paclitaxel ZECO:0000111 chemical treatment XCO:0000736 diphtheria toxin ZECO:0000105 biological treatment biological treatment:diphtheria toxin XCO:0000769 antiserum ZECO:0000105 biological treatment biological treatment:antiserum XCO:0000779 rat IgM immunocytoma cells ZECO:0000105 biological treatment XCO:0000790 controlled sodium chloride content drinking water ZECO:0000239 chemical treatment by diet XCO:0000795 controlled sodium chloride content diet ZECO:0000112 diet diet:controlled sodium chloride content diet XCO:0000798 nociceptin ZECO:0000111 chemical treatment XCO:0000801 controlled gliadin content diet ZECO:0000112 diet XCO:0000818 gene transfer using plasmid vector ZECO:0000105 biological treatment XCO:0000833 lacidipine ZECO:0000111 chemical treatment XCO:0000834 formaldehyde ZECO:0000111 chemical treatment XCO:0000843 mecamylamine ZECO:0000111 chemical treatment XCO:0000844 sodium phenobarbital ZECO:0000111 chemical treatment XCO:0000845 pregnenolone 16alpha-carbonitrile ZECO:0000111 chemical treatment XCO:0000861 control IgG monoclonal antibody ZECO:0000111 chemical treatment XCO:0000879 triamcinolone acetonide ZECO:0000111 chemical treatment XCO:0000880 mifepristone ZECO:0000111 chemical treatment XCO:0000887 pentetrazol ZECO:0000111 chemical treatment XCO:0000888 pilocarpine ZECO:0000111 chemical treatment XCO:0000889 ionomycin ZECO:0000111 chemical treatment XCO:0000891 phorbol 13-acetate 12-myristate ZECO:0000111 chemical treatment XCO:0000897 capsaicin ZECO:0000111 chemical treatment XCO:0000898 minoxidil ZECO:0000111 chemical treatment XCO:0000906 ovalbumin ZECO:0000111 chemical treatment XCO:0000907 liraglutide ZECO:0000111 chemical treatment XCO:0000913 ethosuximide ZECO:0000111 chemical treatment XCO:0000914 cafeteria diet ZECO:0000112 diet XCO:0000922 semaxanib ZECO:0000111 chemical treatment